Which has higher earnings & valuation, OABI or QSI?

OmniAb has higher revenue and earnings than Quantum-Si. OmniAb is trading at a lower price-to-earnings ratio than Quantum-Si, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio OmniAb $18.67M 37.18 -$64.78M -$0.36 N/A Quantum-Si $1.61M 146.60 -$101.34M -$0.46 N/A

Is OABI or QSI more profitable?

OmniAb has a net margin of -115.12% compared to Quantum-Si's net margin of -6,138.26%. OmniAb's return on equity of -16.59% beat Quantum-Si's return on equity. Company Net Margins Return on Equity Return on Assets OmniAb -115.12% -16.59% -14.82% Quantum-Si -6,138.26% -47.12% -43.18%

Which has preferable earnings & valuation, EVO or QSI?

Quantum-Si has lower revenue, but higher earnings than Evotec. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Evotec $717.28M 0.85 -$117.12M N/A N/A Quantum-Si $1.61M 146.60 -$101.34M -$0.46 N/A

Is EVO or QSI more profitable?

Evotec has a net margin of -26.20% compared to Quantum-Si's net margin of -6,138.26%. Evotec's return on equity of -24.93% beat Quantum-Si's return on equity. Company Net Margins Return on Equity Return on Assets Evotec -26.20% -24.93% -11.35% Quantum-Si -6,138.26% -47.12% -43.18%

Does the media favor EVO or QSI?

In the previous week, Quantum-Si had 10 more articles in the media than Evotec. MarketBeat recorded 15 mentions for Quantum-Si and 5 mentions for Evotec. Quantum-Si's average media sentiment score of 0.45 beat Evotec's score of 0.14 indicating that Quantum-Si is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Evotec 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Quantum-Si 6 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Is DNA or QSI more profitable?

Ginkgo Bioworks has a net margin of -259.96% compared to Quantum-Si's net margin of -6,138.26%. Quantum-Si's return on equity of -47.12% beat Ginkgo Bioworks' return on equity. Company Net Margins Return on Equity Return on Assets Ginkgo Bioworks -259.96% -60.27% -26.88% Quantum-Si -6,138.26% -47.12% -43.18%

Does the media refer more to DNA or QSI?

In the previous week, Quantum-Si had 10 more articles in the media than Ginkgo Bioworks. MarketBeat recorded 15 mentions for Quantum-Si and 5 mentions for Ginkgo Bioworks. Quantum-Si's average media sentiment score of 0.45 beat Ginkgo Bioworks' score of 0.27 indicating that Quantum-Si is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Ginkgo Bioworks 0 Very Positive mention(s) 3 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Quantum-Si 6 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media refer more to PACB or QSI?

In the previous week, Quantum-Si had 8 more articles in the media than Pacific Biosciences of California. MarketBeat recorded 15 mentions for Quantum-Si and 7 mentions for Pacific Biosciences of California. Pacific Biosciences of California's average media sentiment score of 0.69 beat Quantum-Si's score of 0.45 indicating that Pacific Biosciences of California is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Pacific Biosciences of California 2 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Quantum-Si 6 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has stronger valuation and earnings, QSI or TKNO?

Alpha Teknova has higher revenue and earnings than Quantum-Si. Alpha Teknova is trading at a lower price-to-earnings ratio than Quantum-Si, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Quantum-Si $1.61M 146.60 -$101.34M -$0.46 N/A Alpha Teknova $43.70M 11.03 -$17.26M -$0.31 N/A

Is QSI or TKNO more profitable?

Alpha Teknova has a net margin of -38.37% compared to Quantum-Si's net margin of -6,138.26%. Alpha Teknova's return on equity of -24.94% beat Quantum-Si's return on equity. Company Net Margins Return on Equity Return on Assets Quantum-Si -6,138.26% -47.12% -43.18% Alpha Teknova -38.37% -24.94% -16.53%

Does the media prefer QSI or TKNO?

In the previous week, Quantum-Si had 13 more articles in the media than Alpha Teknova. MarketBeat recorded 15 mentions for Quantum-Si and 2 mentions for Alpha Teknova. Alpha Teknova's average media sentiment score of 1.17 beat Quantum-Si's score of 0.45 indicating that Alpha Teknova is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Quantum-Si 6 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Alpha Teknova 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Quantum-Si (QSI) Competitors

$1.08 +0.12 (+12.20%)

As of 12:26 PM Eastern

Compare

QSI vs. OABI, EVO, DNA, PACB, and TKNO

Should you buy Quantum-Si stock or one of its competitors? Quantum-Si's main competitors and comparable companies include OmniAb (OABI), Evotec (EVO), Ginkgo Bioworks (DNA), Pacific Biosciences of California (PACB), and Alpha Teknova (TKNO). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "life sciences tools & services" industry.

How does Quantum-Si compare to OmniAb?

OmniAb (NASDAQ:OABI) and Quantum-Si (NASDAQ:QSI) are both small-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, valuation, profitability, risk, earnings, dividends and media sentiment.

In the previous week, Quantum-Si had 14 more articles in the media than OmniAb. MarketBeat recorded 15 mentions for Quantum-Si and 1 mentions for OmniAb. OmniAb's average media sentiment score of 1.79 beat Quantum-Si's score of 0.45 indicating that OmniAb is being referred to more favorably in the media.

Company	Overall Sentiment
OmniAb	Very Positive
Quantum-Si	Neutral

OmniAb has a net margin of -115.12% compared to Quantum-Si's net margin of -6,138.26%. OmniAb's return on equity of -16.59% beat Quantum-Si's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
OmniAb	-115.12%	-16.59%	-14.82%
Quantum-Si	-6,138.26%	-47.12%	-43.18%

OmniAb has a beta of 0.62, indicating that its stock price is 38% less volatile than the broader market. Comparatively, Quantum-Si has a beta of 3.25, indicating that its stock price is 225% more volatile than the broader market.

72.1% of OmniAb shares are owned by institutional investors. Comparatively, 39.9% of Quantum-Si shares are owned by institutional investors. 9.8% of OmniAb shares are owned by insiders. Comparatively, 22.0% of Quantum-Si shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

OmniAb has higher revenue and earnings than Quantum-Si. OmniAb is trading at a lower price-to-earnings ratio than Quantum-Si, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
OmniAb	$18.67M	37.18	-$64.78M	-$0.36	N/A
Quantum-Si	$1.61M	146.60	-$101.34M	-$0.46	N/A

OmniAb currently has a consensus target price of $11.00, indicating a potential upside of 129.41%. Quantum-Si has a consensus target price of $2.50, indicating a potential upside of 132.56%. Given Quantum-Si's higher possible upside, analysts plainly believe Quantum-Si is more favorable than OmniAb.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
OmniAb	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
Quantum-Si	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25

Summary

OmniAb beats Quantum-Si on 9 of the 15 factors compared between the two stocks.

How does Quantum-Si compare to Evotec?

Evotec (NASDAQ:EVO) and Quantum-Si (NASDAQ:QSI) are both small-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their media sentiment, analyst recommendations, valuation, dividends, profitability, earnings, institutional ownership and risk.

Evotec currently has a consensus price target of $3.00, suggesting a potential upside of 75.44%. Quantum-Si has a consensus price target of $2.50, suggesting a potential upside of 132.56%. Given Quantum-Si's stronger consensus rating and higher possible upside, analysts plainly believe Quantum-Si is more favorable than Evotec.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Evotec	1 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Quantum-Si	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25

In the previous week, Quantum-Si had 10 more articles in the media than Evotec. MarketBeat recorded 15 mentions for Quantum-Si and 5 mentions for Evotec. Quantum-Si's average media sentiment score of 0.45 beat Evotec's score of 0.14 indicating that Quantum-Si is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Evotec	1 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Quantum-Si	6 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Quantum-Si has lower revenue, but higher earnings than Evotec.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Evotec	$717.28M	0.85	-$117.12M	N/A	N/A
Quantum-Si	$1.61M	146.60	-$101.34M	-$0.46	N/A

Evotec has a net margin of -26.20% compared to Quantum-Si's net margin of -6,138.26%. Evotec's return on equity of -24.93% beat Quantum-Si's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Evotec	-26.20%	-24.93%	-11.35%
Quantum-Si	-6,138.26%	-47.12%	-43.18%

Evotec has a beta of 1.92, meaning that its stock price is 92% more volatile than the broader market. Comparatively, Quantum-Si has a beta of 3.25, meaning that its stock price is 225% more volatile than the broader market.

5.8% of Evotec shares are held by institutional investors. Comparatively, 39.9% of Quantum-Si shares are held by institutional investors. 22.0% of Quantum-Si shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Summary

Quantum-Si beats Evotec on 10 of the 14 factors compared between the two stocks.

How does Quantum-Si compare to Ginkgo Bioworks?

Ginkgo Bioworks (NYSE:DNA) and Quantum-Si (NASDAQ:QSI) are both small-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, valuation, institutional ownership, earnings, media sentiment, dividends, profitability and analyst recommendations.

78.6% of Ginkgo Bioworks shares are held by institutional investors. Comparatively, 39.9% of Quantum-Si shares are held by institutional investors. 12.7% of Ginkgo Bioworks shares are held by company insiders. Comparatively, 22.0% of Quantum-Si shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Ginkgo Bioworks presently has a consensus price target of $6.33, indicating a potential downside of 50.52%. Quantum-Si has a consensus price target of $2.50, indicating a potential upside of 132.56%. Given Quantum-Si's stronger consensus rating and higher probable upside, analysts clearly believe Quantum-Si is more favorable than Ginkgo Bioworks.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ginkgo Bioworks	2 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Quantum-Si	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25

In the previous week, Quantum-Si had 10 more articles in the media than Ginkgo Bioworks. MarketBeat recorded 15 mentions for Quantum-Si and 5 mentions for Ginkgo Bioworks. Quantum-Si's average media sentiment score of 0.45 beat Ginkgo Bioworks' score of 0.27 indicating that Quantum-Si is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Ginkgo Bioworks	0 Very Positive mention(s)	3 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Quantum-Si	6 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Quantum-Si has lower revenue, but higher earnings than Ginkgo Bioworks. Ginkgo Bioworks is trading at a lower price-to-earnings ratio than Quantum-Si, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ginkgo Bioworks	$132.42M	6.51	-$312.76M	-$5.01	N/A
Quantum-Si	$1.61M	146.60	-$101.34M	-$0.46	N/A

Ginkgo Bioworks has a beta of 1.76, meaning that its stock price is 76% more volatile than the broader market. Comparatively, Quantum-Si has a beta of 3.25, meaning that its stock price is 225% more volatile than the broader market.

Ginkgo Bioworks has a net margin of -259.96% compared to Quantum-Si's net margin of -6,138.26%. Quantum-Si's return on equity of -47.12% beat Ginkgo Bioworks' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Ginkgo Bioworks	-259.96%	-60.27%	-26.88%
Quantum-Si	-6,138.26%	-47.12%	-43.18%

Summary

Quantum-Si beats Ginkgo Bioworks on 12 of the 16 factors compared between the two stocks.

How does Quantum-Si compare to Pacific Biosciences of California?

Pacific Biosciences of California (NASDAQ:PACB) and Quantum-Si (NASDAQ:QSI) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, media sentiment, dividends, earnings, profitability, risk and institutional ownership.

Pacific Biosciences of California presently has a consensus price target of $1.71, suggesting a potential downside of 27.89%. Quantum-Si has a consensus price target of $2.50, suggesting a potential upside of 132.56%. Given Quantum-Si's stronger consensus rating and higher probable upside, analysts clearly believe Quantum-Si is more favorable than Pacific Biosciences of California.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Pacific Biosciences of California	2 Sell rating(s)	3 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.83
Quantum-Si	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25

In the previous week, Quantum-Si had 8 more articles in the media than Pacific Biosciences of California. MarketBeat recorded 15 mentions for Quantum-Si and 7 mentions for Pacific Biosciences of California. Pacific Biosciences of California's average media sentiment score of 0.69 beat Quantum-Si's score of 0.45 indicating that Pacific Biosciences of California is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Pacific Biosciences of California	2 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Quantum-Si	6 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

39.9% of Quantum-Si shares are held by institutional investors. 3.7% of Pacific Biosciences of California shares are held by company insiders. Comparatively, 22.0% of Quantum-Si shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Pacific Biosciences of California has a net margin of -82.49% compared to Quantum-Si's net margin of -6,138.26%. Quantum-Si's return on equity of -47.12% beat Pacific Biosciences of California's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Pacific Biosciences of California	-82.49%	-5,752.12%	-19.52%
Quantum-Si	-6,138.26%	-47.12%	-43.18%

Pacific Biosciences of California has a beta of 2.31, suggesting that its stock price is 131% more volatile than the broader market. Comparatively, Quantum-Si has a beta of 3.25, suggesting that its stock price is 225% more volatile than the broader market.

Quantum-Si has lower revenue, but higher earnings than Pacific Biosciences of California. Pacific Biosciences of California is trading at a lower price-to-earnings ratio than Quantum-Si, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Pacific Biosciences of California	$159.27M	4.64	-$546.38M	-$0.43	N/A
Quantum-Si	$1.61M	146.60	-$101.34M	-$0.46	N/A

Summary

Quantum-Si beats Pacific Biosciences of California on 11 of the 16 factors compared between the two stocks.

How does Quantum-Si compare to Alpha Teknova?

Quantum-Si (NASDAQ:QSI) and Alpha Teknova (NASDAQ:TKNO) are both small-cap healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, risk, media sentiment, valuation, dividends, profitability, analyst recommendations and institutional ownership.

Alpha Teknova has a net margin of -38.37% compared to Quantum-Si's net margin of -6,138.26%. Alpha Teknova's return on equity of -24.94% beat Quantum-Si's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Quantum-Si	-6,138.26%	-47.12%	-43.18%
Alpha Teknova	-38.37%	-24.94%	-16.53%

Quantum-Si currently has a consensus price target of $2.50, indicating a potential upside of 132.56%. Alpha Teknova has a consensus price target of $8.00, indicating a potential downside of 11.01%. Given Quantum-Si's higher probable upside, analysts clearly believe Quantum-Si is more favorable than Alpha Teknova.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Quantum-Si	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
Alpha Teknova	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

Alpha Teknova has higher revenue and earnings than Quantum-Si. Alpha Teknova is trading at a lower price-to-earnings ratio than Quantum-Si, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Quantum-Si	$1.61M	146.60	-$101.34M	-$0.46	N/A
Alpha Teknova	$43.70M	11.03	-$17.26M	-$0.31	N/A

In the previous week, Quantum-Si had 13 more articles in the media than Alpha Teknova. MarketBeat recorded 15 mentions for Quantum-Si and 2 mentions for Alpha Teknova. Alpha Teknova's average media sentiment score of 1.17 beat Quantum-Si's score of 0.45 indicating that Alpha Teknova is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Quantum-Si	6 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Alpha Teknova	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

39.9% of Quantum-Si shares are owned by institutional investors. Comparatively, 13.8% of Alpha Teknova shares are owned by institutional investors. 22.0% of Quantum-Si shares are owned by company insiders. Comparatively, 13.2% of Alpha Teknova shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Quantum-Si has a beta of 3.25, meaning that its stock price is 225% more volatile than the broader market. Comparatively, Alpha Teknova has a beta of 0.72, meaning that its stock price is 28% less volatile than the broader market.

Summary

Alpha Teknova beats Quantum-Si on 9 of the 16 factors compared between the two stocks.

Get Quantum-Si News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding QSI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

QSI vs. The Competition

Export

Metric	Quantum-Si	Life Sciences Tools & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$235.96M	$11.02B	$7.27B	$13.18B
Dividend Yield	N/A	1.45%	2.52%	14.19%
P/E Ratio	-2.34	75.66	274.14	25.75
Price / Sales	146.60	364.15	656.10	90.66
Price / Cash	N/A	27.74	80.06	52.35
Price / Book	1.05	6.80	10.51	6.36
Net Income	-$101.34M	$57.48B	$3.50B	$360.42M
7 Day Performance	41.69%	3.96%	-1.03%	-1.46%
1 Month Performance	37.82%	7.53%	-3.91%	-4.00%
1 Year Performance	-23.76%	40.32%	13.14%	4.03%

Quantum-Si Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
QSI Quantum-Si	2.8899 of 5 stars	$1.08 +12.2%	$2.50 +132.6%	-31.1%	$235.96M	$1.61M	N/A	145	News Coverage Analyst Forecast Options Volume
OABI OmniAb	2.4142 of 5 stars	$4.58 +2.5%	$11.00 +140.2%	+194.4%	$647.18M	$18.67M	N/A	89	Positive News
EVO Evotec	3.0384 of 5 stars	$1.54 -3.8%	$3.00 +94.8%	-53.7%	$569.31M	$891.97M	N/A	4,553	Gap Up High Trading Volume
DNA Ginkgo Bioworks	1.1313 of 5 stars	$8.01 +1.6%	$6.33 -20.9%	-9.3%	$530.64M	$170.15M	N/A	485
PACB Pacific Biosciences of California	0.6765 of 5 stars	$1.36 -0.7%	$1.71 +25.9%	+46.4%	$425.84M	$160.01M	N/A	485	News Coverage Analyst Downgrade Options Volume

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:QSI) was last updated on 9/30/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Quantum-Si (QSI) Competitors

QSI vs. OABI, EVO, DNA, PACB, and TKNO

How does Quantum-Si compare to OmniAb?

Summary

How does Quantum-Si compare to Evotec?

Summary

How does Quantum-Si compare to Ginkgo Bioworks?

Summary

How does Quantum-Si compare to Pacific Biosciences of California?

Summary

How does Quantum-Si compare to Alpha Teknova?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

QSI vs. The Competition

Quantum-Si Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Quantum-Si (QSI) Competitors

QSI vs. OABI, EVO, DNA, PACB, and TKNO

How does Quantum-Si compare to OmniAb?

Does the media refer more to OABI or QSI?

Is OABI or QSI more profitable?

Which has more volatility and risk, OABI or QSI?

Do institutionals & insiders have more ownership in OABI or QSI?

Which has higher earnings & valuation, OABI or QSI?

Do analysts rate OABI or QSI?

Summary

How does Quantum-Si compare to Evotec?

Do analysts rate EVO or QSI?

Does the media favor EVO or QSI?

Which has preferable earnings & valuation, EVO or QSI?

Is EVO or QSI more profitable?

Which has more volatility and risk, EVO or QSI?

Do institutionals & insiders hold more shares of EVO or QSI?

Summary

How does Quantum-Si compare to Ginkgo Bioworks?

Do institutionals and insiders believe in DNA or QSI?

Do analysts prefer DNA or QSI?

Does the media refer more to DNA or QSI?

Which has higher earnings and valuation, DNA or QSI?

Which has more volatility and risk, DNA or QSI?

Is DNA or QSI more profitable?

Summary

How does Quantum-Si compare to Pacific Biosciences of California?

Do analysts rate PACB or QSI?

Does the media refer more to PACB or QSI?

Do insiders and institutionals have more ownership in PACB or QSI?

Is PACB or QSI more profitable?

Which has more volatility and risk, PACB or QSI?

Which has higher earnings and valuation, PACB or QSI?

Summary

How does Quantum-Si compare to Alpha Teknova?

Is QSI or TKNO more profitable?

Do analysts prefer QSI or TKNO?

Which has stronger valuation and earnings, QSI or TKNO?

Does the media prefer QSI or TKNO?

Do institutionals & insiders believe in QSI or TKNO?

Which has more volatility & risk, QSI or TKNO?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

QSI vs. The Competition

Quantum-Si Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools